The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index. [electronic resource]
- BioMed research international 2018
- 9506979 p. digital
Publication Type: Journal Article
2314-6141
10.1155/2018/9506979 doi
Aged Biomarkers, Tumor--genetics Female Humans Leukemia, Lymphocytic, Chronic, B-Cell--diagnosis Male Middle Aged Predictive Value of Tests Prognosis Retrospective Studies